Psychiatry and Clinical Psychopharmacology

Oromandibular Dystonia Treatment With Aripiprazole in an Adolescent Patient 2-Year Follow-Up: A Case Report


Department of Child and Adolescent Psychiatry, Ondokuz Mayis University School of Medicine, Samsun, Turkey

Psychiatry and Clinical Psychopharmacology 2021; 31: 358-360
DOI: 10.5152/pcp.2021.21068
Read: 75 Downloads: 35 Published: 23 September 2021

Oromandibular dystonia (OMD) is a movement disorder that can cause considerable functional and psychosocial disability such as dysphagia, dysarthria, breathing difficulty, weight loss, social withdrawal, and depression. Oromandibular dystonia has no known cure. Many different treatment approaches can be used for the treatment of OMD. In this case report, we present a 16-year-old female adolescent patient with OMD, who showed a significant improvement with the use of 5 mg/day aripiprazole during
the 2-year follow-up.

Cite this article as: Gümüş YY, Say GN. Oromandibular dystonia treatment with aripiprazole in an adolescent patient 2-year follow-up: A case report. Psychiatr Clin Psychopharmacol. 2021;31(3):358-360.

EISSN 2475-0581